Israeli biotech Mitoconix Bio is developing a new treatment for Huntington’s disease and other neurodegenerative disorders. It works by inhibiting mitochondrial splitting. Mitochondria contribute to important brain functions, including regulation of cell growth.
http://www.timesofisrael.com/israeli-startup-takes-aim-at-huntingtons-disease/